Kezdőlap Mélykutatási eredmények QA Jelek Területek Módszertan Névjegy Keresés Rákkutatás Publikációk, biológiai célpontok, gyógyszerek, bizonyítékszintek és klinikai vizsgálatok.
A rákkutatási terület evidencialétrát használ a sejtmodelltől a klinikai gyakorlatig. A rendszer kutatási tájékozódást ad, nem diagnosztizál és nem választ kezelést.
Jelek Three Versus 6 Months of Adjuvant Oxaliplatin‑Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial — Colorectal cancerRecent advancements in lung cancer research: a narrative review — NSCLCA prospective investigation of early‑onset colorectal cancer risk factors – pooled analysis of three large‑scale European cohorts — Colorectal cancerSmall cell lung cancer – Trials in Disease – Overview of Information and Clinical Research — SCLCAdjuvant Quisinostat in High-Risk Uveal Melanoma - NCT06932757 — MelanomaLung cancer in non-smokers — NSCLCAdvances in Prostate Cancer Treatment: Exploring Molecular Targets and New Strategies in Castration-Resistant Disease — Prostate cancerKRAS-targeted therapies in colorectal cancer: a systematic analysis of mutations, inhibitors, and clinical trials — Colorectal cancerAdvancing breast, lung and prostate cancer research with federated learning. A systematic review — Breast cancerBreaking barriers in prostate cancer: the mRNA vaccine breakthrough and what comes next — Prostate cancerOvercoming colorectal cancer and cancer stem cell resistance with photodynamic therapy: new frontiers in oncology — Colorectal cancerGut Microbiome Alterations in Colorectal Cancer: Mechanisms, Therapeutic Strategies, and Precision Oncology Perspectives — Colorectal cancerUnderstanding prostate cancer care: recent progress and future direction — Prostate cancerHope on the Horizon: Emerging Therapies for SCLC — SCLCDurable complete response of advanced hepatocellular carcinoma using cannabis oil: a report of two cases — Hepatocellular carcinomaUnlocking glioblastoma: breakthroughs in molecular mechanisms and next‑generation therapies — GlioblastomaA radio-genomics biomarker for precision epidermal growth factor receptor mutation targeting therapy in non‑small cell lung cancer — NSCLCAcute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‑Stratification, and Management — LeukemiaRegorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single‑arm, open‑label, phase II clinical trial — Colorectal cancerA randomized controlled trial of a digital lifestyle intervention involving postoperative patients with colorectal cancer — Colorectal cancerElőző 55/102 Következő